2006•Wuhan Daxue xuebao. Yixue banRequires access

Effect of Nasal Bi-level Positive Airway Pressure on 29 Chronic Obstructive Pulmonary Disease Patients with Chronic Respiratory Failure

Zhu Hu

Open publisher page 0 citations

Abstract

Objective: To investigate the effect of nasal bi-level positive airway pressure(BiPAP) on patients with chronic obstructive pulmonary disease(COPD) complicated with chronic respiratory failure.Methods: All 29 COPD patients with chronic respiratory failure were treat with BiPAP.The arterial blood gas were analysed and the parameters of lung ventilation function were measured before BiPAP and 2 and 12 hours after treatment.Results: Before BiPAP treatment,the parameters of arterial blood gas and lung ventilation function were PaCO_(2)(65±15) mmHg,PaO_(2)(45±15) mmHg,pH(7.28±0.10),FVC(1.25±0.20) L,FEV_(1)(0.65±0.08) L,respectively.Two hours after BiPAP,the parameters changed as PaCO_(2)(60±13) mmHg,PaO_(2)(75±15)mmHg,pH(7.30±0.12),FVC(1.28±0.18) L and FEV_(1)(0.80±0.10) L,respectively.And 12 hours after treatment,the parameters are PaCO_(2)(58±12) mmHg,PaO_(2)(80±15)mmHg,pH((7.33)±0.13),FVC(1.33±0.20) L and FEV_(1)(0.85±0.15) L.Both the levels of PaO_(2) and FEV_(1) had significant changes after the use of BiPAP.(Conclusion:) Nasal BiPAP may be considered a good treatment option for patients with COPD complicated with chronic respiratory failure due to its good improvement of PaO_(2) and FEV_(1).

About this research paper

What this paper is about

Objective: To investigate the effect of nasal bi-level positive airway pressure(BiPAP) on patients with chronic obstructive pulmonary disease(COPD) complicated with chronic respiratory failure.Methods: All 29 COPD patients with chronic respiratory failure were treat with BiPAP.The arterial blood gas were analysed and the parameters of lung ventilation function were measured before BiPAP and 2 and 12 hours after treatment.Results: Before BiPAP treatment,the parameters of arterial blood gas and lung ventilation function were PaCO_(2)(65±15) mmHg,PaO_(2)(45±15) mmHg,pH(7.28±0.10),FVC(1.25±0.20) L,FEV_(1)(0.65±0.08) L,respectively.Two hours after BiPAP,the parameters changed as PaCO_(2)(60±13) mmHg,PaO_(2)(75±15)mmHg,pH(7.30±0.12),FVC(1.28±0.18) L and FEV_(1)(0.80±0.10) L,respectively.And 12 hours after treatment,the parameters are PaCO_(2)(58±12) mmHg,PaO_(2)(80±15)mmHg,pH((7.33)±0.13),FVC(1.33±0.20) L and FEV_(1)(0.85±0.15) L.Both the levels of PaO_(2) and FEV_(1) had significant changes after the use of BiPAP.(Conclusion:) Nasal BiPAP may be considered a good treatment option for patients with COPD complicated with chronic respiratory failure due to its good improvement of PaO_(2) and FEV_(1).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the effect of nasal bi-level positive airway pressure(BiPAP) on patients with chronic obstructive pulmonary disease(COPD) complicated with chronic respiratory failure.Methods: All 29 COPD patients with chronic respiratory failure were treat with BiPAP.The arterial blood gas were analysed and the parameters of lung ventilation function were measured before BiPAP and 2 and 12 hours after treatment.Results: Before BiPAP treatment,the parameters of arterial blood gas and lung ventilation function were PaCO_(2)(65±15) mmHg,PaO_(2)(45±15) mmHg,pH(7.28±0.10),FVC(1.25±0.20) L,FEV_(1)(0.65±0.08) L,respectively.Two hours after BiPAP,the parameters changed as PaCO_(2)(60±13) mmHg,PaO_(2)(75±15)mmHg,pH(7.30±0.12),FVC(1.28±0.18) L and FEV_(1)(0.80±0.10) L,respectively.And 12 hours after treatment,the parameters are PaCO_(2)(58±12) mmHg,PaO_(2)(80±15)mmHg,pH((7.33)±0.13),FVC(1.33±0.20) L and FEV_(1)(0.85±0.15) L.Both the levels of PaO_(2) and FEV_(1) had significant changes after the use of BiPAP.(Conclusion:) Nasal BiPAP may be considered a good treatment option for patients with COPD complicated with chronic respiratory failure due to its good improvement of PaO_(2) and FEV_(1).

Key concepts: Medicine, COPD, Positive airway pressure, Anesthesia, Arterial blood, Ventilation (architecture), Respiratory failure, Respiratory system

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Nasal Bi-level Positive Airway Pressure on 29 Chronic Obstructive Pulmonary Disease Patients with Chronic Respiratory Failure — Research Paper | ScholarLens